文献速递慢性肾脏病肾小球疾病

联合总肾脏体积与肾衰竭风险方程在常染色体显性多囊肾病中的验证

Validation of Combining Total Kidney Volume and Kidney Failure Risk Equation in Autosomal Dominant Polycystic Kidney Disease.
PubMed 文献 · Kidney Int Rep · 2026-03-18

本研究为回顾性观察研究,纳入2015年1月至2023年1月期间有CT或MRI总肾脏体积(TKV)的成人常染色体显性多囊肾病(ADPKD)患者,评估在Mayo影像分类(MIC)基础上加入肾衰竭风险方程(KFRE)对复合终点(肾脏替代治疗启动或eGFR下降40%)的预测性能。主要分析eGFR<60 ml/min/1.73 m2患者,结果显示包含年龄、性别、托伐普坦、KFRE和MIC值的调整模型预测性能最佳。

要点

  • 在eGFR<60 ml/min/1.73 m2的ADPKD患者中,MIC联合KFRE可改善风险预测。
  • 调整模型(含年龄、性别、托伐普坦、KFRE和MIC值)预测性能最佳。
  • KFRE单独使用也有较好预测性能,但联合MIC更优。

核心结论

  • 在基线eGFR<60 ml/min/1.73 m2的ADPKD队列中,KFRE联合MIC可改善风险预测,支持两者联合使用。

研究设计与样本

  • 回顾性观察研究,纳入2015年1月至2023年1月期间有CT或MRI-derived TKV的成人ADPKD患者。

主要发现

  • 在eGFR<60 ml/min/1.73 m2组,调整模型(年龄、性别、托伐普坦、KFRE和MIC值)AIC=631,1、3、5年ΔC-statistic分别为0.47、0.28、0.27。
  • MIC值联合KFRE模型AIC=641,1、3、5年ΔC-statistic分别为0.47、0.26、0.26。
  • KFRE单独模型AIC=642,1、3、5年ΔC-statistic分别为0.47、0.26、0.28。

临床怎么用

  • 对eGFR<60 ml/min/1.73 m2的ADPKD患者,可考虑联合使用MIC和KFRE进行风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Total kidney volume (TKV) interpreted via the Mayo Imaging Classification (MIC) is the recommended prognostication tool in autosomal dominant polycystic kidney disease (ADPKD), but further risk stratification is often needed. The kidney failure risk equation (KFRE) is validated in chronic kidney disease (CKD) of diverse etiologies, but its use in patients with ADPKD already assessed via the MIC is unclear. This study evaluated the impact of adding KFRE to MIC. METHODS: Adults with ADPKD with ≥1 computed tomography (CT) or magnetic resonance imaging (MRI) derived TKV available between January 2015 and January 2023 were included in this retrospective observational study. The predictive performance of models including the MIC value, baseline estimated glomerular filtration rate (eGFR), and 5-year KFRE score, and fully adjusted models were examined using the composite outcome of kidney replacement therapy initiation or eGFR decline 40%. The primary analysis was in patients with eGFR < 60 ml/min per 1.73 m2. RESULTS: In the eGFR < 60 ml/min per 1.73 m2 group, compared with the model showing MIC value alone, the adjusted model including age, sex, tolvaptan, KFRE, and MIC value demonstrated the best performance (Akaike information criterion [AIC] = 631, ΔC-statistic = 0.47, 0.28, and 0.27 at 1, 3, and 5 years respectively), followed closely by the combination of MIC value and KFRE (AIC = 641, ΔC-statistic = 0.47, 0.26, and 0.26), KFRE alone (AIC = 642, ΔC-statistic = 0.47, 0.26, and 0.28) at 1, 3, and 5 years respectively. CONCLUSION: In the cohort with a baseline eGFR < 60 ml/min per 1.73 m2, use of the KFRE in addition to the MIC improved risk prediction, supporting the utilization of these tools together in ADPKD.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Bevilacqua M, Guan M, Romann A, et al. Validation of Combining Total Kidney Volume and Kidney Failure Risk Equation in Autosomal Dominant Polycystic Kidney Disease. Kidney Int Rep. 2026. PMID: 42027549. doi:10.1016/j.ekir.2026.106489

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。